LENVATINIB
Clinical trials for LENVATINIB explained in plain language.
Never miss a new study
Get alerted when new LENVATINIB trials appear
Sign up with your email to follow new studies for LENVATINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New triple therapy targets Hard-to-Treat bile duct cancer
Disease control Not yet recruitingThis study tests a combination of three drugs (disitamab vedotin, lenvatinib, and a PD-1 inhibitor) in 65 adults with advanced HER2-positive bile duct cancer that cannot be removed by surgery. The goal is to see if the combo shrinks tumors and controls the disease. Participants w…
Matched conditions: LENVATINIB
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 26, 2026 09:50 UTC
-
Second-line hope for liver cancer: regorafenib tested after lenvatinib failure
Disease control Not yet recruitingThis study tests a drug called regorafenib in about 24 adults with advanced liver cancer that did not respond to the first treatment, lenvatinib. The goal is to see if regorafenib can slow tumor growth and improve survival. Participants will take regorafenib pills and have regula…
Matched conditions: LENVATINIB
Phase: PHASE2 • Sponsor: Ju Hyun Shim • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
AI reads cancer slides to pick best Post-Op therapy
Knowledge-focused Not yet recruitingThis study aims to create an AI tool that analyzes standard liver cancer tissue images to predict which patients will benefit from additional treatments after surgery. The goal is to avoid unnecessary side effects and improve outcomes by personalizing care. The study will involve…
Matched conditions: LENVATINIB
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC